Partner With Us NRI

Aster DM Healthcare Ltd share Price

Company details

6M Return 40.44%
1Y Return 32.91%
Mkt Cap.(Cr) 16,923.50
Volume 1,516,045
Div Yield 0.00%
OI Chg %
Volume 1,516,045

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Numbers driven by strong GCC performance…
About The Stock

    Aster operates in segments like hospitals, clinics, retail pharmacies and provides healthcare services to patients across economic segments in several GCC states through various brands such as Aster, Medcare and Access.

    • Its network consists of 13 hospitals, 109 clinics and 240 retail pharmacies in GCC states;14 hospitals, 11 clinics, 131 pharmacies and 114 labs in India; total bed capacity: GCC: 1160, India: 3905
    • Revenue break-up FY22: hospitals: 56%, pharmacies: 21%, clinics: 23% with GCC & India contributing 77% & 23% of revenues, respectively

    Aster DM reported in line numbers driven by GCC - hospitals, pharmacies and clinics (up 12% YoY) and India operations (up 26% YoY).

    • Sales were up 14% YoY to ₹ 2728 crore
    • EBITDA was at ₹ 463 crore, up 44% YoY with margins at 17%
    • Consequent PAT was at ₹ 226 crore (up 115% YoY)

Click here for full recommendation

Research view on more stocks

Aster DM Healthcare announced Q1FY24 results:

  • Operational revenue grew 21% YoY to Rs 3,215 crore Vs. Rs 2,662 crore in Q1FY23.
  • EBITDA grew 33% YoY to Rs 388 crore Vs. Rs 292 crore in Q1FY23.
  • Reported net profit after taxes was at Rs 5 crore compared to Rs 69 crore in Q1FY23.
  • Excluding new hospitals and non-recurring exceptional items, Net profit after taxes grew 87% YoY to Rs 84 crore

Commenting on the performance for Q1FY24, Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, said, “During Q1FY24, we achieved an impressive 21% YoY consolidated revenue growth, totaling Rs 3,215 crore. Our performance during the quarter was shaped by not only the improvement in our realizations but also the increase in the number of beds at existing hospitals as well as at the new facilities to cater to growing demand. The strong growth across both India and GCC regions and various cost improvement initiatives enabled even higher improvement in our EBITDA performance which recorded a robust growth of 33% to Rs 388 crore.

Our India business continued to grow faster, witnessing a substantial increase of 29% in revenues reaching Rs 838 crore, and EBITDA increasing by 47% to Rs 123 crore. While our project pipeline is advancing significantly, we are also building on our O&M-Asset Light strategy which has the potential to generate higher ROCE over a period. We are excited to announce our collaboration with PMF Hospital in Kollam, Kerala. With this we have added a total of 530 beds under the O&M Asset Light model in less than 2 years, making it a significant milestone.

Overall, our Q1 performance reflects our adaptability, strategic expansion, and unwavering commitment to providing quality healthcare services amidst evolving market dynamics.”


Result PDF

View Other Company Results


Investment recommendation
Numbers driven by strong GCC performance…
Call Date
15 Feb 2023
Entry Price 210.00
Target Price 280.00
12-18 Month


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Aster DM Healthcare Ltd Stocks COMPARISION


Equity Capital: 4,448.07 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 16,852.71 -20,671.82
LAST 3M 52,922.55 -3,405.64
LAST 6M 58,662.39 139,660.95
LAST 12M 135,235.34 165,245.59

Aster DM Healthcare Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Aster DM Healthcare Ltd. is an Indian conglomerate healthcare provider. It operates medical centres, diagnostic centres, laboratories, hospitals, and pharmacies in the Middle East and India. The company was incorporated in 1987 with headquarters in Dubai, UAE. During FY 2021-2022, Aster DM Healthcare Ltd. Reported a total revenue of Rs 10,303.94 crore, up 19.01% against Rs 8,658.40 crore recorded in the previous financial year, 2020-2021. On 14 October 2022, the company’s market capitalisation stood at Rs 12,080 crore.

    The company is listed on the Bombay Stock Exchange with the code 540975, and on the National Stock Exchange with the code ASTERDM.

    Aster DM Healthcare Ltd. provides services in areas like dental, diabetology, general medicine, cardiology, dermatology, endocrinology, dietetics, ENT, general surgery, neurology, orthopaedics, psychiatry, gynaecology, gastroenterology, ophthalmology, paediatrics, pulmonology, and urology. The company was formerly called Dr Moopen Group and changed its name to DM Healthcare Ltd. in 2008.

    On 30 June 2022, the company’s shareholding pattern showed a 37.88% promoter stake, 11.44% foreign institutional investor stake, 9.65% domestic institutional investor stake, and 40.57% public stake. Union Investments Pvt Ltd. is the leading promoter with a 37.41% stake. In the June 2022 quarter, the promoters’ pledge remained unchanged at 10.44% of the holdings, while mutual fund holdings increased from 8.12% to 9.62%.

    The founder of Aster DM Healthcare Ltd. is Mr Azad Moopen. The company’s leadership team comprises Ms Fara Siddiqui, Dr Malathi Arshanapalai, Mr Veneeth Purushotaman, Dr Shanila Laiju, Mr Brandon Rowberry, Mr N S Balasubramanian, Mr T J Wilson, Ms Alisha Moopen, and Mr Sreenath P Reddy. Its auditors are Deloitte Haskins & Sells. As of 30 June 2022, the company had a total of 49.95 crore shares outstanding.

    On 14 October 2022, the company’s share price closed at Rs 241.90 on BSE. It closed at Rs 241.85 on NSE. Aster DM Healthcare Ltd.’s 52-week high share price was Rs 265.55, and the 52-week low share price was Rs 158.

    The company’s peers include Apollo Hospitals Enterprises Ltd., Max Healthcare Institute Ltd., Fortis Healthcare Ltd., and Dr Lal PathLabs Ltd.

    As of September 2022, HDFC Small Cap Fund had a 3.01% stake in the company. SBI Contra Fund, ICICI Prudential Smallcap Fund, and HDFC Children’s Gift Fund had 2.19%, 1.83%, and 1.49% stakes, respectively.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose

Registered Address

IX/475L Aster Medcity, Kuttisahib Road Cheranalloore, Kochi, Kerala, 682027

Tel : 91-0484-6699228
Email : investors:asterdmhealthcare.com
Website : http://www.asterdmhealthcare.com

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540975
Book Closure Date (Month) :
BSE Group : A
ISIN : INE914M01019

FAQ’s on Aster DM Healthcare Ltd Shares

You can buy Aster DM Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aster DM Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Oct 03, 2023 03:59 PM the closing price of Aster DM Healthcare Ltd was ₹ 338.80.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 03, 2023 03:59 PM, the market cap of Aster DM Healthcare Ltd stood at ₹ 16,923.50.

The latest PE ratio of Aster DM Healthcare Ltd as of Oct 03, 2023 03:59 PM is 46.95

The latest PB ratio of Aster DM Healthcare Ltd as of Oct 03, 2023 03:59 PM is 0.24

The 52-week high of Aster DM Healthcare Ltd is ₹ 354.95 while the 52-week low is ₹ 201.30

According to analyst recommendations, Aster DM Healthcare Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app